REGISTERED NUMBER: 07452401 (England and Wales)

Lucas-Chave Dermatology Limited

Unaudited Financial Statements for the Year Ended 30 November 2025

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

T Chave

L Lucas-Chave

SECRETARY:

L Lucas-Chave

REGISTERED OFFICE:

One New Street

Wells

Somerset

BA5 2LA

REGISTERED NUMBER:

07452401 (England and Wales)

ACCOUNTANTS:

Webb & Co Ltd

Accountants and Business Advisers

One New Street

Wells

Somerset

BA5 2LA

FIXED ASSETS

Tangible assets

4

24,933

26,914

Investment property

5

575,000

575,000

599,933

601,914

CURRENT ASSETS

Debtors

6

73,217

81,250

Cash at bank

379,743

472,303

452,960

553,553

CREDITORS

Amounts falling due within one year

7

92,112

87,940

NET CURRENT ASSETS

360,848

465,613

TOTAL ASSETS LESS CURRENT LIABILITIES

960,781

1,067,527

PROVISIONS FOR LIABILITIES

76,754

77,250

NET ASSETS

884,027

990,277

CAPITAL AND RESERVES

Called up share capital

8

10

10

Fair value reserve

244,827

244,827

Retained earnings

639,190

745,440

SHAREHOLDERS' FUNDS

884,027

990,277

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 27 August 2026 and were signed on its behalf by:

T Chave - Director

1.	STATUTORY INFORMATION

Lucas-Chave Dermatology Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

The company recognises revenue when the amount of revenue can be reliably measured, it is probable that future economic benefits will flow to the entity; and specific criteria have been met for each of the company's activities.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Freehold property

-

No depreciation

Plant and machinery

-

20% on cost

Computer equipment

-

33% on cost

Investment property

Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2024 - 3 ) .

4.	TANGIBLE FIXED ASSETS

Freehold

Plant and

Computer

property

machinery

equipment

Totals

£

£

£

£

COST

At 1 December 2024

and 30 November 2025

20,599

9,900

1,829

32,328

DEPRECIATION

At 1 December 2024

-

3,585

1,829

5,414

Charge for year

-

1,981

-

1,981

At 30 November 2025

-

5,566

1,829

7,395

NET BOOK VALUE

At 30 November 2025

20,599

4,334

-

24,933

At 30 November 2024

20,599

6,315

-

26,914

5.	INVESTMENT PROPERTY

Total

£

FAIR VALUE

At 1 December 2024

and 30 November 2025

575,000

NET BOOK VALUE

At 30 November 2025

575,000

At 30 November 2024

575,000

If investment properties had not been revalued they would have been included at the following historical cost: £254,502. Investment properties were revalued by the directors at 30 November 2025.

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

33,889

58,930

Other debtors

39,328

22,320

73,217

81,250

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade creditors

4,476

1,109

Taxation and social security

81,251

81,230

Other creditors

6,385

5,601

92,112

87,940

8.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2025

2024

value:

£

£

10

Ordinary

£1

10

10

9.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 30 November 2025 and 30 November 2024:

2025

2024

£

£

T Chave and L Lucas-Chave

Balance outstanding at start of year

10,538

11,879

Amounts advanced

27,185

10,538

Amounts repaid

(10,538

)

(11,879

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

27,185

10,538